Przejdź do głównej treści

Widok zawartości stron Widok zawartości stron

News

Nawigacja okruszkowa Nawigacja okruszkowa

Widok zawartości stron Widok zawartości stron

Scientists call for protection of biomedicine from false claims

Scientists call for protection of biomedicine from false claims

In a first-time report, the European Academies of Science (EASAC) and Medicine (FEAM) call upon European lawmakers to protect biomedical science from false claims. Experts from all over Europe caution that enthusiasm on the potential of regenerative medicine applications has led to a gap between the expectations and realities of translating regenerative medicine technologies into clinical practice. According to them, some regulators have become increasingly permissive in an era of stark competition on the global medicine and healthcare market.

The report has been published on the Polish Academy of Sciences website along with a commentary by Prof. Józef Dulak, Head of the Department of Medical Biotechnology at the JU Faculty of Biochemistry, Biophysics and Biotechnology, speaking on behalf of the Committee of Biotechnology at the Polish Academy of Sciences:

“It is very good that the EASAC-FEAM has issued a statement on this very important issue, which has become even more relevant in the time of SARS Cov-2 pandemic, when researchers and physicians are expected to propose quick and effective solutions to global health problems. The EASAC-FEAM experts warn against taking shortcuts by resorting to miracle cures and treatment methods, based on conviction and belief, instead of scientifically proven facts and reliable research.

The report on regenerative medicine points to serious problems related to offering medically unproven and potentially dangerous stem cell treatments, warning not only against commercial entities offering such therapies, but also against the excessive permissiveness of regulators allowing unproven experimental treatment methods. It should be noted that such procedures, referred to as medical experiments, are often costly for patients, and permitting such invasive forms of treatment by bioethical commissions should be a matter of concern for the medical community and the relevant supervisory bodies. At this point, it is worthwhile to quote the EASAC-FEAM report:

‘Although there are considerable scientific and clinical opportunities, there are also major concerns. First, there is an increasing problem in some countries of commercial clinics offering unregulated products and services, promising a wide range of benefits using poorly characterised medicinal products with little evidence of effectiveness, vague rationale and with the primary intention of financial profit. Secondly, there is premature marketing approval and commercialisation of approaches based on some, but insufficient, evidence as a result of evolving business models facilitated by regulatory authority initiatives for accelerated access.’

The EASAC-FEAM report corresponds to the statement of the Committee for Advanced Therapies of the European Medicines’ Agency (CAT EMA) published in late April. The publication of these two documents should be followed by specific actions undertaken by relevant medical and governmental bodies in Poland in order to protect patients as consumers of commercial medical services. It would be very unfortunate if the problem is again ignored as irrelevant, as in the case of the CAT EMA statement.

It is time take some concrete steps, which have long been called for by the Committee of Biotechnology at the Polish Academy of Sciences … Patients must be protected against expensive and potentially dangerous illusions.”  

The report is available at the link below.

Pliki do pobrania
pdf
EASAC-FEAM Report on Regenerative Medicine
Polecamy również
Ambassador of Sri Lanka visits the Jagiellonian University

Ambassador of Sri Lanka visits the Jagiellonian University

Scientists continue to increase their knowledge of virus biology

Scientists continue to increase their knowledge of virus biology

Project co-authored by JU MC student awarded in the Direction: Space competition

Project co-authored by JU MC student awarded in the Direction: Space competition

Ambassador of Iceland visits the Jagiellonian University

Ambassador of Iceland visits the Jagiellonian University

Widok zawartości stron Widok zawartości stron